For most people, cancer is a frightening diagnosis that is fraught with confusion. For Eric Lefkofsky, it was eye-opening. When his wife, Elizabeth, was diagnosed with cancer, he realized just how difficult it is for patients and their families to understand what is going on and how best to combat their disease. Lefkofsky decided to come up with a solution. He joined forces with Brad Keywell to develop a startup called Tempus.
This was nothing new for the pair. They are long-time business partners who have developed multiple startups together in the past. Lefkofsky is a prominent tech founder based in Chicago who has built a fortune with his entrepreneurial spirit. Some of his startups include Groupon, Lightbank, and Uptake Technologies. He also works as an adjunct professor at the University of Chicago. In 2007 he published a book called Accelerated Disruption: Understanding the True Speed of Innovation.
Lefkofsky has used his position to give back to the community. He and his wife created the Lefkofsky Family Foundation to support initiatives that better the lives of the people served. Lefkofsky also serves as a Trustee for several Chicago-based organizations, including Lurie Children’s Hospital of Chicago and The Museum of Science and Industry and Eric’s lacrosse camp.
Now, with Tempus, Lefkofsky is offering new hope to the cancer community. Tempus uses data from genomic sequencing to develop the best course of treatment for each individual patient based on their specific tumors. This information helps both patients and doctors by providing them with the data they need to make informed decisions and learn more about Eric.
Tempus also has a centralized database that doctors can access. They can use the data on past cancer patients who have similarities to their current patients to see what was most effective for them. That makes Tempus a game-changer when it comes to treating cancer patients.